Description
Cagrilintide Technical Overview
Cagrilintide is an investigational long-acting analogue of amylin, a peptide hormone involved in metabolic and neuroendocrine signaling.
It was developed to investigate prolonged activation of amylin receptor-associated pathways. Amylin receptors consist of calcitonin receptor complexes interacting with receptor activity-modifying proteins.
Clinical research has investigated Cagrilintide alone and in combination with Semaglutide. Clinical findings cannot establish the activity of an independently manufactured research preparation.
Compound Specifications
| Property | Value |
|---|---|
| Compound Name | Cagrilintide |
| Classification | Long-acting amylin analogue |
| Related Hormone | Amylin |
| Research Target | Amylin receptor system |
| Research Category | Metabolic Research |
| Vial Content | 10mg |
Storage and Handling
- Follow manufacturer-validated storage requirements.
- Protect from moisture, light, and contamination.
- Account for peptide formulation stability.
Lyophilized Format
Cagrilintide may be manufactured in lyophilized form. Stability depends on its specific chemical and pharmaceutical formulation.
Research Use Disclaimer
This preparation is described for laboratory research only and is not represented as an FDA-approved Cagrilintide medicine. Not intended for human or veterinary administration.
Frequently Asked Questions
What Is Cagrilintide?
An investigational long-acting analogue of amylin.
What Is Amylin?
A peptide hormone involved in metabolic regulation.
Which Receptors Are Involved?
Amylin receptor complexes.
Is Cagrilintide the Same as Semaglutide?
No. They activate different receptor systems.
What Research Areas Involve Cagrilintide?
Amylin signaling and metabolic regulation.
Research Overview
Cagrilintide has been investigated in clinical and experimental research focused on long-acting amylin receptor agonism.
Amylin Receptor Research
Studies examine activation of amylin-associated receptor complexes.
Metabolic Research
Investigations have evaluated Cagrilintide-associated metabolic outcomes.
Combination Research
Studies have examined Cagrilintide together with GLP-1 receptor agonists.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| Amylin Receptors | Receptor signaling assays |
| Peptide Pharmacology | Long-acting analogue characterization |
| Metabolic Biology | Experimental endocrine signaling |
References
- Lau DCW, Erichsen L, Francisco AM, et al. (2021). Once-Weekly Cagrilintide for Weight Management in People With Overweight and Obesity. The Lancet. Publication record.
Certificate of Analysis (COA)
Documentation should establish compound identity, peptide purity, and actual content.
Reviews
There are no reviews yet.